Purchase this article with an account.
F. Molle, G. D'Amico, D. Lepore, A. Baldascino, F. Focosi, E. Balestrazzi; Minimal Central Vitrectomy by TSV 25 G and Intravitreal Triamcinolone Acetonide With or Without Inner Limiting Membrane Removal in Diabetic Diffuse Macular Edema Treatment . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1436.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: To determine whether Vitrectomy 25 Gauge and Intravitreal Injection of Triamcinolone with or without internal limiting membrane (ILM) peeling reduces diffuse diabetic macular thickening and edema. Methods: We analyzed the surgical outcomes in 10 eyes of 6 patients with diffuse diabetic macular edema who underwent minimal vitrectomy and intravitreal triamcinolone (4mg). Four eyes (Group A, medium macular thickness 720 ±20 micron) underwent three–port pars plana Transconjunctival Sutureless Vitrectomy 25 Gauge (TSV 25 G) with posterior hyaloid membrane (PHM) removal. Six eyes (Group B, medium macular thickness 700±20 micron) had pars plana TSV 25 G with additional ILM peeling after PHM removal. Visual acuity (ETDRS) and central macular thickness at 1, 3, and 6 months were measured by Optical Coherence Tomography (STRATUS OCT 3). Results: In Group A, residual medium macular thickness was 260±20 micron with one line improvement visual acuity. At the same time, in group B edema resolved completely (medium macular thickness 188micron) in 5 eyes with a two lines visual acuity improvement. Conclusions: Minimal Central Vitrectomy by TSV 25 G with ILM peeling seems more effective and long–lasting than standard Intravitreal Triamcinolone Acetonide without ILM peeling in reducing diffuse diabetic macular edema.
This PDF is available to Subscribers Only